Get started
Author

Mamiko Takeuchi

Observed names: M Takeuchi, MAMIKO TAKEUCHI, Mamiko TAKEUCHI
Institution: Anjo Kosei Hospital
OpenAlex ID: A5111790779
Elevation of serum cystatin C concentrations in patients with chronic liver disease
2001 · Mamiko Takeuchi, Yoshihide Fukuda, et al. · European Journal of Gastroenterology & Hepatology · 56
Initial clinical experience with durvalumab plus tremelimumab in patients with unresectable hepatocellular carcinoma in real‑world practice
2024 · Shigeo Shimose, Issei Saeki, et al. · Oncology Letters · 22
PDF
Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapy
2024 · Issei Saeki, Shigeo Shimose, et al. · PLoS ONE · 20
PDF
Fatal Bleeding from a Residual Vein at the Esophageal Ulcer Base After Successful Endoscopic Variceal Ligation
2001 · Hidenori Toyoda, Yoshihide Fukuda, et al. · Journal of Clinical Gastroenterology · 15
An autopsy case of multilocular cystic hepatocellular carcinoma without liver cirrhosis.
2000 · K Nagano, Y Fukuda, et al. · PubMed · 12
A case of the development of two hepatocellular carcinomas and a cholangiocarcinoma with cirrhosis after elimination of serum hepatitis C virus RNA with interferon therapy.
2000 · K Nagano, Y Fukuda, et al. · PubMed · 11
Distribution of Fibrosis‐4 index and vibration‐controlled transient elastography‐derived liver stiffness measurement for patients with metabolic dysfunction‐associated steatotic liver disease in health check‐up
2024 · Yuji Ogawa, Wataru Tomeno, et al. · Hepatology Research · 7
PDF
A novel approach to evaluate the therapeutic efficacy of durvalumab and tremelimumab combination therapy in hepatocellular carcinoma
2025 · Tetsu Tomonari, Shigeo Shimose, et al. · Hepatology Research · 4
Antitumor effects and immune‐mediated adverse events of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma
2024 · Takanori Ito, Shigeo Shimose, et al. · Hepatology Research · 4
PDF
A Case of fascioliasis
2020 · Yuki Yamanaka, Mamiko Takeuchi · Kanzo · 4
PDF
[A case of ischemic colitis induced by hypereosinophilic syndrome].
2012 · Yuhei Ichikawa, Mamiko Takeuchi, et al. · PubMed · 4
Association of Metabolic‐Associated Steatotic Liver Disease With Clinical Outcomes of Durvalumab and Tremelimumab in Advanced Hepatocellular Carcinoma Patients: A Multicenter Study
2025 · Takeshi Hatanaka, Shigeo Shimose, et al. · Hepatology Research · 3
389. Benefits of Bilateral Thoracoscopic Surgery in the Prone Position for a Large Esophageal Tumor
2022 · Norihisa Uemura, Makoto Ishihara, et al. · Diseases of the Esophagus · 2
The non-surgical treatments of hepatocellular carcinomas in a patient with severe hemophilia A.
1999 · H Toyoda, Y Fukuda, et al. · PubMed · 2
Early Changes in Lymphocyte Counts Predict Clinical Outcomes in Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab
2026 · Yuichi Honma, Shigeo Shimose, et al. · Journal of Gastroenterology and Hepatology · 1
PDF
[The usefulness of percutaneous transhepatic cholecyst puncture (PTCCP) with ultrasoundimage control for acute cholecystitis].
1996 · M Tanikawa, M Ichikawa, et al. · PubMed · 1
Atezolizumab plus Bevacizumab Versus Durvalumab plus Tremelimumab in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study
2026 · Yasuto Takeuchi, Shigeo Shimose, et al. · Liver Cancer
PDF
WED-283 The distribution of fibrosis-4 index and vibration-controlled transient elastography-derived liver stiffness measurement for patients with metabolic dysfunction associated steatotic liver disease in the general population
2024 · Yuji Ogawa, Wataru Tomeno, et al. · Journal of Hepatology
The therapeutic effect and immune-related adverse event of nivolmab in Anjo Kosei Hospital
2019 · Yuichiro Inagaki, Hirofumi Yokota, et al. · Annals of Oncology
PDF
Intervention by PCT and Problems Awaiting Solution at Anjo Kosei Hospital: Usefulness of Rounds of Patients Receiving Opioids
2012 · Kazuyuki NAKAMURA, Takanori MIURA, et al. · JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE
PDF
Toll-like receptor 2 signaling is important for fas ligand on NKT cells, may contribute to liver injury induced by Salmonella infection
2001 · Hideyuki Shimizu, Yoshide Fukuda, et al. · Gastroenterology
Serum cystatin C levels in patients with chronic liver disease
2000 · Yoshiaki Katano, Yoshihide Fukuda, et al. · Gastroenterology
PDF
The Expression of TIMP‐3 in Hepatoma Cell Lines
1999 · YOSHIAKI KATANO, YOSHIHIDE FUKUDA, et al. · Annals of the New York Academy of Sciences
Works count: 23
Citation count: 168
H-index: 7
I10-index: 6
Year
Topic
Type